# John Bertrand

> John Bertrand is a healthcare technology operator, adviser, and board director who spent nearly 13 years at Epic Systems before becoming CEO and later a designated co-founder of Digital Diagnostics. He led the company from a research-oriented organization toward commercial scale, then moved into a Chief Innovation Officer role at PartsSource and joined OraSure Technologies' board in 2026.

- **Role:** Chief Innovation Officer at PartsSource; Director at OraSure Technologies
- **Organizations:** PartsSource, OraSure Technologies, Digital Diagnostics, Epic Systems Corporation, 8VC, Bain Capital, KeyCare, Surlogs, Sirona Medical, Innovaccer, iRhythm Technologies, Digital Surgery, Matrix Capital Management
- **Nationality:** American
- **Education:** B.S. in Business Management, Purdue University
- **Known for:** Led Digital Diagnostics' transition from a primarily research-driven organization to a commercial enterprise and global AI diagnostics platform., Helped guide the reimbursement process for IDx-DR after its FDA clearance., Led Digital Diagnostics during its $75 million Series B financing announced in August 2022.

## Career timeline

- **2006-2019** — Held product, customer success, business development, and other leadership roles at Epic Systems Corporation.
- **2016-2018** — Served on the Board of Advisors of Matrix Capital Management.
- **2018-2020** — Served in roles including Executive in Residence and Senior Advisor at 8VC, focused on healthcare technology.
- **2018-2020** — Served on the Board of Advisors of Digital Surgery.
- **2019** — Joined the board of Digital Diagnostics and became CEO in December.
- **2019-present** — Serves on the Board of Directors of Sirona Medical and Digital Diagnostics.
- **2019-2020** — Served as an adviser to Innovaccer and iRhythm Technologies.
- **2020-present** — Serves on the Board of Directors of Surlogs.
- **2022** — Received a board-confirmed co-founder designation at Digital Diagnostics; joined the Board of Directors of KeyCare.
- **2023** — Began serving as a Senior Advisor to Bain Capital's private equity practice in healthcare IT, diagnostics, and therapeutics.
- **2025-12** — Concluded his tenure as Chief Executive Officer of Digital Diagnostics.
- **2026** — Became Chief Innovation Officer at PartsSource.
- **2026-04** — Joined the OraSure Technologies board as an independent director and member of its Nominating and Corporate Governance Committee.

## Achievements

- Led Digital Diagnostics' transition from a primarily research-driven organization to a commercial enterprise and global AI diagnostics platform.
- Helped guide the reimbursement process for IDx-DR after its FDA clearance.
- Led Digital Diagnostics during its $75 million Series B financing announced in August 2022.
- Helped accelerate development and deployment of FDA-cleared diagnostic systems across multiple disease areas.
- Was designated a co-founder of Digital Diagnostics by its board in 2022 in recognition of his contribution to the company's growth.
- Joined OraSure Technologies' board in 2026 as an independent director.

## Latest updates

- **2026-06** — Received a restricted stock grant connected with service on the OraSure Technologies board, according to an SEC Form 4.
- **2026-04** — Joined the OraSure Technologies board as an independent director and member of the Nominating and Corporate Governance Committee.
- **2026** — Became Chief Innovation Officer at PartsSource, working on clinical capacity through data- and AI-driven asset orchestration.
- **2025-12** — Ended his tenure as Chief Executive Officer of Digital Diagnostics after serving since 2019.

## Links

- Website: https://www.digitaldiagnostics.com/
- LinkedIn: https://www.linkedin.com/in/-johnbertrand/

---

Profile page: https://yespress.io/john-bertrand
Published by YesPress — https://yespress.io
Last updated: 2026-08-18